Smoking remains the primary cause of preventable death in the United States and smoking related illness costs more than $300 billion annually. Nicotine (the primary reinforcer in cigarettes) causes changes in behavior and neurochemistry that lead to increased probability of relapse. Given the role of mesolimbic dopamine projections in motivation, substance use disorder, and drug relapse, we examined the effect of repeated nicotine on rapid dopamine signals in the nucleus accumbens (NAc) of rats. Adult, male Sprague-Dawley rats were exposed to nicotine (0.2 or 0.4 mg/kg, subcutaneous) once daily for 7 days. On day 8, dopamine release and uptake dynamics, and their modulation by nicotinic receptor agonists and antagonists, were assessed using fast scan cyclic voltammetry in the NAc core. Nicotine exposure decreased electricallystimulated dopamine release across a range of stimulation frequencies and decreased 62-containing nicotinic receptor control over dopamine release. Additionally, nicotine locomotor sensitization correlated with accumbal dopamine modulation by nicotine and mecamylamine.
Introduction
Smoking tobacco is the number one cause of preventable death in the United States, with 480,000 individuals dying each year from cigarette use and second-hand smoke exposure (U.S.
Department of Health and Human Services, 2014) . Nicotine, the main reinforcer in tobacco, is a primary reinforcer that has been shown to support self-administration, increase and sensitize locomotor activity, and drive drug-seeking behavior (Stolerman & Shoaib, 1991; De Biasi & Dani, 2011) . Additionally, nicotine enhances the reinforcing effects and incentive motivation of stimuli that accompany tobacco use (Caggiula et al., 2009 ).
Nicotinic acetylcholine receptors (nAChRs) are necessary for both the primary reinforcing and reinforcement enhancing effects of nicotine. Activation of nAChRs in the nucleus accumbens or in the VTA can directly increase dopamine release in the striatum (Cachope et al., 2012; Threlfell et al., 2012) and systemic nAChR antagonism decreases nicotine self-administration (Corrigall & Coen, 1989; DeNoble & Mele, 2006; Yoshimura et al., 2007) . In addition, NAc nAChRs modulate dopamine release in a frequency dependent manner (Zhang & Sulzer, 2004) . Dopamine neurons switch between tonic (~4-5 Hz) and phasic (2-5 spikes at 20-100 Hz) patterns of firing during the presentation of reinforcers or reward-related cues (Waelti et al., 2001; Tobler et al., electrically-stimulated dopamine release in the NAc core (Zhang et al., 2012; Exley et al., 2013) .
The same studies also found that oral nicotine self-administration decreased the influence of 2-containing nAChRs (Zhang et al., 2012) and 6-containing nAChRs (Exley et al., 2013) over dopamine release in the NAc core. Repeated nicotine also decreases 62* receptor control over dopamine release in the NAc shell and ventral putamen of nonhuman primates (Perez et al., 2009 (Perez et al., , 2012 .
Our lab has recently shown individual variation in the degree to which nAChRs modulate dopamine release in the NAc core and that this variation correlates with a behavioral measure of vulnerability to high levels of early drug intake (Siciliano et al., 2017) . Dopamine release in the NAc core is necessary for the incentive motivation of cues (Saunders & Robinson, 2012) and cueinduced drug seeking (Bossert et al., 2007; Saunders et al., 2013) . Given the importance of nAChRs in modulating NAc dopamine release and their role in the dual-reinforcement effects of nicotine, chronic nicotine may modulate dopamine signals in a manner that drives further cueinduced drug seeking and use.
Additionally, it has been hypothesized that locomotor sensitization to nicotine is a marker of vulnerability to nicotine addiction (DiFranza & Wellman, 2007) . Given our previous work, we were also interested in whether individual differences in nicotine-induced locomotor sensitization would correlate with nicotine-induced changes in nAChR modulation of dopamine release. / 5% CO2) artificial cerebral spinal fluid (aCSF) containing (in mM): NaCl (126), KCl (2.5), monobasic NaH2PO4 (1.2), CaCl2 (2.4), MgCl2 (1.2), NaHCO3 (25), dextrose (D-glucose) (11), and L-ascorbic acid (0.4). Tissue was sectioned into 400 m-thick coronal striatal slices with a compresstome ® VF-300 vibrating microtome (Precisionary Instruments, San Jose, California).
Brain slices were placed in submersion recording chambers and then perfused at 1mL/min at 32ºC with oxygenated aCSF.
FSCV was used to assess dopamine release in the NAc core in rat brain slices ( Figure   1A ). A bipolar stimulating electrode was placed 100-150 M from a carbon-fiber recording electrode (100-200 m length, 7 µm diameter) in the NAc core ( Figure 1A ). Dopamine release was initially evoked by a single electrical pulse (750 A, 2 msec, monophasic) applied to the tissue every 3 minutes.
Extracellular dopamine was recorded by applying a triangular waveform from -0.4 to 1.2 V and back to -0.4 (Ag vs AgCl) at a scan rate of 400 V/s using by a carbon fiber electrode.
Voltammograms were recorded at the carbon fiber electrode every 100msec. Once dopamine response was stable (three consecutive collections with <10% variability), five-pulse stimulations were applied at varying burst frequencies (5, 10, 20, or 100 Hz) to model the physiological range of dopamine neuron firing. After assessing the dopamine response to single and multi-pulse stimulations, various compounds targeting nAChRs (nicotine, 500 nM; mecamylamine [MEC] , 2 M; dihydro-beta-erythroidine [DHE] , 500 nM; α-conotoxin MII [α-Ctx MII], 100 nM) were bath applied and dopamine response equilibrated (three collections within 10% variability) to single pulse stimulation. Separate slices from the same animal were used to test each drug independently, and the same frequency-response curves assessed under drug-free conditions were reassessed following drug application in each slice. In order to test the distinct contributions of α6* and non-α6* nAChRs, we added α-Ctx MII and DhE in a cumulative fashion, equilibrating and testing single and multi-pulse frequencies (described above) following α-Ctx MII and then DhβE. Changes in dopamine signaling between -Ctx MII [a selective α6 nAChR antagonist (Nicke et al., 2004) ] alone and in combination with DHE (a 2 nAChR antagonist) differentiated the contribution of 6* and non-6* 2-containing nAChRs. We focused on nAChRs containing 6 subunits due to its role in modulating dopamine release in the NAc (Wickham et al., 2013; Siciliano et al., 2017) .
Demon Voltammetry and Analysis software was used to acquire and model FSCV data (Yorgason et al., 2011) . Recording electrodes were calibrated by recording electrical current responses (in nA) to a known concentration of dopamine (3 M) using a flow-injection system.
This was used to convert electrical current to dopamine concentration. Michaelis-Menten kinetics were used to determine maximal rate of dopamine uptake (Vmax) (Ferris et al., 2013) .
Statistical analysis
Single pulse dopamine release and Vmax were compared by one-way ANOVA and
Tukey's multiple comparison in case of significance. Dopamine release across multiple frequency stimulations was normalized to each subject's pre-drug single pulse dopamine release. Multipulse dopamine release and locomotor activity were compared by two-or three-factor mixed design ANOVA. In the case of significant interactions, Bonferroni post-hoc comparisons were used. Percent changes in dopamine release following drug application were compared using twotailed unpaired t-tests or two-factor mixed design ANOVA. Locomotor sensitization was assessed using one-sample t-tests against no change. Pearson product-moment correlation was used to assess the relationship between nicotine locomotor sensitization and nicotine-and MEC-induced modulation of dopamine release. All statistics were performed using GraphPad Prism 7 (Graphpad Software, La Jolla, CA) or SPSS v. 24 (International Business Machine Corporation, Armonk, NY) with ≤ 0.05. Values >2 standard deviations above or below the mean were considered outliers and excluded. Data are presented as mean ± SEM.
Results

Repeated nicotine exposure decreases dopamine release in the NAc core
We first examined whether repeated exposure to nicotine altered dopamine release in the NAc core. Rats were exposed to nicotine (0.2 or 0.4 mg/kg, s.c.) for seven consecutive days, then ex vivo voltammetry was used to assess dopamine release in the NAc core the day after the final injection of nicotine (Fig. 1A) . Repeated injections of nicotine significantly decreased the 
6-containing nAChR regulation of dopamine release is altered following repeated nicotine
To examine whether repeated exposure to nicotine had functional consequences on nAChR modulation of dopamine release in the NAc core, we assessed dopamine release across a range of frequencies following bath application of drugs that target nAChRs. Reductions in dopamine release to single pulse stimulations, in particular, could be attributed to reductions in acetylcholine (ACh) facilitation of dopamine release magnitude. Striatal cholinergic interneurons (CIN) increase dopamine release in the NAc core by activating nAChRs on dopamine terminals (Cachope et al., 2012; Threlfell et al., 2012; Brimblecombe et al., 2018) and antagonism or desensitization of nAChRs decreases single pulse dopamine release (Rice & Cragg, 2004) .
Surprisingly, a history of nicotine exposure did not alter the magnitude of decrease in dopamine release to single pulse stimulations following a desensitizing dose of nicotine (t32 = 0.098, p = 0.922) ( Fig. 2A ) or MEC (a non-selective nAChR antagonist) (t12 = 0.87, p = 0.401) (Fig. 2B ).
We next used selective nAChR antagonists to examine whether 2* nAChR-modulation of dopamine was altered by repeated exposure to nicotine since 2-containing nAChRs are necessary for the reinforcing effects of nicotine and for nicotine-induced increases in NAc dopamine (Picciotto et al., 1998; Maskos et al., 2005) . To determine this, we examined dopamine release following a bath application of DHβE [a 2-selective antagonist (500 nM Since nAChRs modulate dopamine release in a frequency dependent manner and the effects of cholinergic and nicotine-induced modulation of dopamine on behavior are hypothesized to be mediated by frequency-dependent gating of dopamine (Rice & Cragg, 2004) , we wanted to examine the effects of nicotine and non-selective and selective nAChR antagonists across a range of physiologically relevant frequencies in the NAc core. To determine this, we used five pulse stimulations across a range of frequencies to model tonic-and phasic-like firing patterns before and after nicotine or nAChR antagonism. As expected, nicotine modulated dopamine release in a frequency-dependent manner, decreasing dopamine release to single pulse and low frequency stimulation, but not to the highest frequency stimulation (interaction drug*frequency:
F4, 124 = 15.383, p < 0.001). However, repeated nicotine exposure did not change nicotine-induced modulation of dopamine release (main effect of group: F1, 31 = 0.026, p = 0.874) (Fig. 3A) . Similar to the effects of nicotine, MEC decreased single pulse and low frequency dopamine release, but did not affect high frequency dopamine release, and this modulation was not changed by a history of nicotine exposure (main effect of group: F1, 13 = 0.001, p = 0.982; interaction drug*frequency:
F4, 52 = 5.419, p = 0.001) (Fig. 3B) .
To determine the role of 2-containing nAChRs and isolate the role of 6 and non-6
containing 2* nAChRs on dopamine release to tonic and phasic firing patterns, we applied DHE alone and following application of -Ctx MII. As with nicotine, DHE decreased dopamine to single pulse and low frequency stimulations, but not to the highest frequency stimulations (interaction drug*frequency: F4, 104 = 22.468, p < 0.001). Interestingly, DHE decreased dopamine release across the range of stimulation frequencies significantly more in saline treated rats than rats with repeated nicotine exposure (interaction drug*group: F1, 26 = 7.608, p = 0.011) (Fig. 3C ). In agreement with this effect being driven by α6-containing nAChRs, dopamine release was significantly higher in rats with repeated nicotine exposure following -Ctx MII application (interaction drug*group: F1, 10 = 4.905, p = 0.05) (Fig. 3D) . Additionally, DHE did not significantly affect dopamine release in saline or nicotine treated rats when applied after -Ctx MII (main effect of drug: F1, 8 = 0.739, p = 0.415), although rats with repeated nicotine exposure did have higher dopamine release than saline treated rats at the two highest frequency stimulations following -Ctx MII and subsequent DHE (interaction group*frequency: F4, 32 = 4.148, p = 0.008) (Fig. 3E) .
The magnitude of nicotine sensitization predicts nicotine-induced modulation of striatal dopamine release at phasic firing frequencies
Repeated exposure to nicotine increases nicotine-induced locomotion and nicotine sensitization is hypothesized to be a marker of vulnerability to nicotine addiction (DiFranza & Wellman, 2007) . Previous work from our lab has shown that nAChR modulation of dopamine release in the NAc core correlates with another model of vulnerability (high and low responders) (Siciliano et al., 2017) . Because of these findings, we were interested in whether nAChR modulation of dopamine release may predict locomotor sensitization following repeated nicotine exposure. Acute nicotine and repeated saline did not affect locomotion. As expected, repeated nicotine injections increased locomotion following a nicotine injection, but did not alter baseline locomotion (interaction drug*time*day: F20, 1020 = 4.994, p < 0.001) (Fig. 4A ). Repeated injections of nicotine significantly increased nicotine-induced locomotion (one-sample t-test: t31 = 7.31, p < 0.001), while repeated saline did not alter locomotion following a saline injection (one sample ttest: t21 = 0.881, p = 0.388) (Fig. 4A ).
There was individual variation in how much repeated nicotine sensitized nicotine-induced locomotion. We examined whether locomotor sensitization to nicotine predicted the effects of nicotine on dopamine release in the NAc core. Locomotor sensitization to nicotine did not correlate with the effects of nicotine on tonic frequency stimulation of dopamine (5 Hz: r = 0.514, p = 0.088) (Fig. 4B ), but did correlate with nicotine-induced modulation of dopamine following phasic firing rates (20 Hz: r = 0.632, p = 0.028) (Fig. 4C ). In agreement with the effects of nicotine, locomotor sensitization did not correlate with MEC-induced modulation of dopamine release to tonic firing rates (5 Hz: r = 0.488, p = 0.326) (Fig. 4D ), but did correlate with dopamine release to phasic firing stimulation (20 Hz: r = 0.87, p = 0.024) (Fig. 4E ).
Discussion
Our study demonstrates that seven consecutive days of nicotine injections in rats significantly reduced dopamine release magnitude in the NAc core following single pulse electrical stimulation and five pulse stimulations at frequencies ranging from 5 Hz to 100 Hz. This reduction (Zhang et al., 2012; Exley et al., 2013) and the NAc shell and ventral putamen of squirrel monkeys following several months of oral nicotine treatment (Perez et al., 2009 (Perez et al., , 2012 . Our model of seven days of repeated nicotine injections in rats produced a magnitude of dopamine reduction more similar to the effect sizes in monkeys compared to the studies in mice. Additionally, our effects were not due to differences in dopamine uptake through the dopamine transporter since Vmax was not changed by nicotine exposure.
We next examined the degree to which these nicotine-induced reductions in dopamine release could be attributed to reductions in acetylcholine (ACh) facilitation of dopamine release magnitude. Previous work has established that striatal cholinergic interneurons (CIN) supply abundant ACh to the NAc, which can facilitate dopamine release magnitude via nAChRs located directly on dopamine axons. Indeed, acute 2* blockade or desensitization lowers the probability of dopamine release in response to single pulse and multiple pulse stimulations that model tonic firing of dopamine neurons (Rice & Cragg, 2004; Zhang & Sulzer, 2004; Zhang et al., 2009 ). 62-containing nAChRs dominate ACh influence over dopamine release in the ventral striatum / NAc core, while 5-containing nAChRs play a larger role in the dorsal striatum (Exley et al., 2008) .
Thus, we hypothesized that if ACh release from CINs was blunted (or has less influence over dopamine release) in the NAc core following repeated nicotine injections, then both 2 and 6 selective antagonists would be less effective at reducing dopamine release in nicotine treated rats compared to saline treated rats. Consistent with this hypothesis, both the 2 selective antagonist, DHE, and the 6 selective antagonist, -Ctx MII, were less effective at reducing dopamine release in animals treated with nicotine. The nonselective antagonist, mecamylamine, and a desensitizing dose of nicotine decreased dopamine equally in both saline and repeated nicotine groups. The difference in outcome between these nonselective (or desensitizing) compounds and the 62 selective compounds is unclear. One major difference between these classes of drugs is that the nonselective compounds also bind 7 nAChRs, which are located on glutamate afferents in our slice preparation and could effectively reduce excitatory drive onto dopamine axons when blocked or desensitized with mecamylamine or nicotine, respectively. A reduction in excitatory drive on dopamine axons has the potential to decrease dopamine release to floor effects and mask the 62* mediated effects observed using our selective antagonists.
Regardless, the involvement of 62* nAChRs is consistent with previous voltammetric studies that showed 62-containing receptors are primarily responsible for nAChR-evoked dopamine release in the ventral striatum. This is further supported by the fact that DHE had no effect on dopamine release magnitude when administered after -Ctx MII, suggesting minimal contribution from non-6 containing nAChRs (Exley et al., 2008; Siciliano et al., 2017) to our nicotine treatment differences in dopamine release.
We next examined whether repeated nicotine injections sensitized locomotor response to nicotine challenge, as previously reported (see DiFranza & Wellman, 2007) , and whether the degree to which sensitized locomotor activity relates to the magnitude of nicotine's effect on NAc phasic signals in a slice. We show that a seven day regimen of once daily nicotine injections (0.4 mg/kg, s.c.) sensitizes locomotor activity, with nicotine treated rats more than doubling their locomotor activity after the sixth nicotine injection compared to the first. Although elevations in locomotor activity are the most robust ≤ 15 minutes post injection, elevations are sustained through the entire session. We also found that the magnitude of nicotine-induced locomotor sensitization is not predicted by changes in tonic (5 Hz) stimulations following bath application of either nicotine or MEC, but did positively correlate with changes to phasic (20 Hz) dopamine release with both nicotine and MEC. This data is particularly interesting given our previous data that phasic, but not tonic, dopamine release magnitude following bath application of nicotine and MEC correlates with locomotor response to novelty (Siciliano et al., 2017) , a strong predictor of acquisition rates for several drugs of abuse (Piazza et al., 1989; Mantsch et al., 2001; Ferris et al., 2013) . Thus, nicotine modulation of NAc core phasic dopamine release correlates with two markers of vulnerability to substance use disorders: one in drug naïve animals and one following repeated drug exposure. This generality suggests that striatal nAChR modulation of NAc core dopamine (or the interaction of striatal acetylcholine and dopamine) may be a potential biomarker of vulnerability to SUD, or directly mediate SUD vulnerability. Indeed, recent work has shown mechanistic links between ACh signaling through nAChRs on dopamine axons and modulation of cue-induced motivation for natural rewards (Collins et al., 2019) . Future studies will need to explore whether such findings extend to drug seeking.
In conclusion, we found that repeated nicotine injections blunt dopamine release equally across a range of stimulation frequencies that model both tonic and phasic firing of dopamine neurons and that repeated nicotine decreased the ability of 62-containing nAChRs to modulate dopamine release. This deficit in dopamine function may underlie, in part, increased vulnerability to nicotine use following repeated exposure to nicotine. In particular, CIN modulation of dopamine release (mediated through nAChRs) is thought to be essential for reward-related learning (Cragg, 2006) and dysregulation of this system may alter responses to rewards (i.e., nicotine) and rewardrelated cues in a manner that drive nicotine use disorder. We also extended our earlier work on the relationships between locomotor response to either novelty or acute nicotine and dopamine release magnitude following nicotine administration in the NAc. Indeed, we found that nicotine locomotor sensitization, a potential marker of vulnerability to nicotine dependence, correlates with nicotine and MEC modulation of phasic dopamine release. Together, these data suggest that repeated nicotine exposure alters nAChR control over dopamine release in the NAc core in a manner that is consistent with changes that may serve as a biomarker for vulnerability to nicotine use, or a mechanism for such vulnerability.
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